Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema.
D000328:Adult; D000799:Angioedema / Q000188:drug therapy*; D007611:Aprotinin / Q000627:therapeutic use*; D002199:Capillary Permeability / Q000187:drug effects; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced; D007610:Kallikreins / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D014581:Urticaria / Q000188:drug therapy*
D007611:Aprotinin; D007610:Kallikreins